Cholesterol and myelin biogenesis

Sub-Cellular Biochemistry

Volumn 51, Issue , 2010, Pages 489-508

  Saher, Gesine ^c   Simons, Mikael ^a,b  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c NONE

Author keywords

Cholesterol; Myelin; Oligodendrocyte; Schwann cell

Indexed keywords

CHOLESTEROL;

ANIMAL; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOLOGY; HUMAN; MEMBRANE FLUIDITY; METABOLISM; MYELIN SHEATH; OLIGODENDROGLIA; PHYSIOLOGY; REVIEW; SCHWANN CELL; ULTRASTRUCTURE;

ANIMALS; CELL DIFFERENTIATION; CHOLESTEROL; HUMANS; MEMBRANE FLUIDITY; MEMBRANE MICRODOMAINS; MYELIN SHEATH; OLIGODENDROGLIA; SCHWANN CELLS;

EID: 77952307606     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-90-481-8622-8_18     Document Type: Article

References (90)

1. Adlkofer, K., Martini, R., Aguzzi, A., Zielasek, J., Toyka, K. V., and Suter, U., 1995, Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 11:274–80.
2. Amici, S. A., Dunn, W. A., Jr., Murphy, A. J., Adams, N. C., Gale, N. W., Valenzuela, D. M., Yancopoulos, G. D., and Notterpek, L., 2006, Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. J Neurosci 26:1179–89.
3. Baron, W., Colognato, H., and ffrench-Constant, C., 2005, Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49:467–79.
4. Barres, B. A., Lazar, M. A., and Raff, M. C., 1994a, A novel role for thyroid hormone, glu-cocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097–108.
5. Barres, B. A., and Raff, M. C., 1999, Axonal control of oligodendrocyte development, J Cell Biol 147(6):1123–8.
6. Barres, B. A., Raff, M. C., Gaese, F., Bartke, I., Dechant, G., and Barde, Y. A., 1994b, A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367:371–5.
7. Baumann, N., and Pham-Dinh, D., 2001, Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871–927.
8. Bosse, F., Hasse, B., Pippirs, U., Greiner-Petter, R., and Müller, H.W., 2003, Proteolipid plas-molipin: Localization in polarized cells, regulated expression and lipid raft association in CNS and PNS myelin. J Neurochem 86:508–18.
9. Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., and Taylor, J. M., 1985, Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501–13.
10. Bu, G., 2009, Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333–44.
11. Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., Thompson, W. J., and Barres, B. A., 2008, A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28:264–78.
12. D’Antonio, M., Michalovich, D., Paterson, M., Droggiti, A., Woodhoo, A., Mirsky, R., and Jessen, K. R., 2006, Gene profiling and bioinformatic analysis of Schwann cell embryonic development and myelination. Glia 53:501–15.
13. Dietschy, J. M., and Turley, S. D., 2004, Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375–97.
14. Dietschy, J. M., and Wilson, J. D., 1968, Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control. J Clin Invest 47:166–74.
15. Dobbing, J., 1963, The Blood-Brain Barrier: Some Recent Developments. Guys Hosp Rep 112:267–86.
16. Dong, Z., Sinanan, A., Parkinson, D., Parmantier, E., Mirsky, R., and Jessen, K. R., 1999, Schwann cell development in embryonic mouse nerves. J Neurosci Res 56:334–48.
17. Dubois-Dalcq, M., Behar, T., Hudson, L., and Lazzarini, R. A., 1986, Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J Cell Biol 102:384–92.
18. Edmond, J., Korsak, R. A., Morrow, J. W., Torok-Both, G., and Catlin, D. H., 1991, Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J Nutr 121:1323–30.
19. Emery, B., Agalliu, D., Cahoy, J. D., Watkins, T. A., Dugas, J. C., Mulinyawe, S. B., Ibrahim, A., Ligon, K. L., Rowitch, D. H., and Barres, B. A., 2009, Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138:172–85.
20. Erne, B., Sansano, S., Frank, M., and Schaeren-Wiemers, N., 2002, Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J Neurochem 82:550–62.
21. Espenshade, P. J., and Hughes, A. L., 2007, Regulation of sterol synthesis in eukaryotes. Annu Rev Genet 41:401–27.
22. Fitzner, D., Schneider, A., Kippert, A., Mobius, W., Willig, K. I., Hell, S. W., Bunt, G., Gaus, K., and Simons, M., 2006, Myelin basic protein-dependent plasma membrane reorganization in the formation of myelin. Embo J 25:5037–48.
23. Fu, Q., Goodrum, J. F., Hayes, C., Hostettler, J. D., Toews, A. D., and Morell, P., 1998, Control of cholesterol biosynthesis in Schwann cells. J Neurochem 71:549–55.
24. Giese, K. P., Martini, R., Lemke, G., Soriano, P., and Schachner, M., 1992, Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565–76.
25. Goodrum, J. F., Fowler, K. A., Hostettler, J. D., and Toews, A. D., 2000, Peripheral nerve regeneration and cholesterol reutilization are normal in the low-density lipoprotein receptor knockout mouse. J Neurosci Res 59:581–6.
26. Grinspan, J. B., Marchionni, M. A., Reeves, M., Coulaloglou, M., and Scherer, S. S., 1996, Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16:6107–18.
27. Hanson, M. A., Cherezov, V., Griffith, M. T., Roth, C. B., Jaakola, V. P., Chien, E. Y., Velasquez, J., Kuhn, P., and Stevens, R. C., 2008, A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure 16:897–905.
28. Harauz, G., Ishiyama, N., Hill, C. M., Bates, I. R., Libich, D. S., and Fares, C., 2004, Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 35:503–42.
29. Horton, J. D., 2002, Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans 30:1091–5.
30. Huttner, W. B., and Zimmerberg, J., 2001, Implications of lipid microdomains for membrane curvature, budding and fission. Curr Opin Cell Biol 13:478–84.
31. Jessen, K. R., and Mirsky, R., 2005, The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 6:671–82
32. Jessen, K. R., and Mirsky, R., 2008, Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56:1552–65.
33. Jurevics, H., Bouldin, T. W., Toews, A. D., and Morell, P., 1998, Regenerating sciatic nerve does not utilize circulating cholesterol. Neurochem Res 23:401–6.
34. Jurevics, H., and Morell, P., 1995, Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem 64:895–901.
35. Kirby, B. B., Takada, N., Latimer, A. J., Shin, J., Carney, T. J., Kelsh, R. N., and Appel, B., 2006, In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nat Neurosci 9:1506–11.
36. Klopfleisch, S., Merkler, D., Schmitz, M., Kloppner, S., Schedensack, M., Jeserich, G., Althaus, H. H., and Bruck, W., 2008, Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. J Neurosci 28:13609–14.
37. Kramer-Albers, E. M., Gehrig-Burger, K., Thiele, C., Trotter, J., and Nave, K. A., 2006, Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligoden-droglia: implications for dysmyelination in spastic paraplegia. J Neurosci 26:11743–52.
38. Le Douarin, N. M., and Dupin, E., 2003, Multipotentiality of the neural crest. Curr Opin Genet Dev 13:529–36.
39. Leblanc, S. E., Srinivasan, R., Ferri, C., Mager, G. M., Gillian-Daniel, A. L., Wrabetz, L., and Svaren, J., 2005, Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. J Neurochem 93:737–48.
40. Lemke, G., and Axel, R., 1985, Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40:501–8.
41. Li, H., Yao, Z., Degenhardt, B., Teper, G., and Papadopoulos, V., 2001, Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci U S A 98:1267–72.
42. Lund, E. G., Xie, C., Kotti, T., Turley, S. D., Dietschy, J. M., and Russell, D. W., 2003, Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem 278:22980–8.
43. Lutjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Siden, A., Diczfalusy, U., and Bjorkhem, I., 1996, Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A 93: 9799–804.
44. Martini, R., Mohajeri, M. H., Kasper, S., Giese, K. P., and Schachner, M., 1995, Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 15:4488–95.
45. Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A., and Pfrieger, F. W., 2001, CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354–7.
46. Michailov, G. V., Sereda, M. W., Brinkmann, B. G., Fischer, T. M., Haug, B., Birchmeier, C., Role, L., Lai, C., Schwab, M. H., and Nave, K. A., 2004, Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700–3.
47. Miller, R. H., 2002, Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 67:451–67.
48. Miron, V. E., Zehntner, S. P., Kuhlmann, T., Ludwin, S. K., Owens, T., Kennedy, T. E., Bedell, B. J., and Antel, J. P., 2009, Statin therapy inhibits remyelination in the central nervous system. Am J Pathol 17:1880–90.
49. Mirsky, R., Winter, J., Abney, E. R., Pruss, R. M., Gavrilovic, J., and Raff, M. C., 1980, Myelin-specific proteins and glycolipids in rat Schwann cells and oligodendrocytes in culture. J Cell Biol 84:483–94.
50. Morell, P., and Jurevics, H., 1996, Origin of cholesterol in myelin. Neurochem Res 21:463–70.
51. Morell, P., and Norton, W. T., 1980, Myelin. Sci Am 242:88–90, 92, 96 passim.
52. Muse, E. D., Jurevics, H., Toews, A. D., Matsushima, G. K., and Morell, P., 2001, Parameters related to lipid metabolism as markers of myelination in mouse brain. J Neurochem 76:77–86.
53. Musse, A. A., Gao, W., Homchaudhuri, L., Boggs, J. M., and Harauz, G., 2008, Myelin basic protein as a "PI(4,5)P2-modulin": a new biological function for a major central nervous system protein. Biochemistry 47:10372–82.
54. Nagarajan, R., Le, N., Mahoney, H., Araki, T., and Milbrandt, J., 2002, Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc Natl Acad Sci USA 99:8998–9003.
55. Nave, K. A., and Salzer, J. L., 2006, Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol 16:492–500.
56. Nawaz, S., Kippert, A., Saab, A. S., Werner, H. B., Lang, T., Nave, K. A., and Simons, M., 2009, Phosphatidylinositol 4,5-bisphosphate-dependent interaction of myelin basic protein with the plasma membrane in oligodendroglial cells and its rapid perturbation by elevated calcium. J Neurosci 29:4794–807.
57. Noble, M., Murray, K., Stroobant, P., Waterfield, M. D., and Riddle, P., 1988, Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560–2.
58. Osono, Y., Woollett, L. A., Herz, J., and Dietschy, J. M., 1995, Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest 95:1124–32.
59. Peles, E., and Salzer, J. L., 2000, Molecular domains of myelinated axons. Curr Opin Neurobiol 10:558–65.
60. Pertusa, M., Morenilla-Palao, C., Carteron, C., Viana, F., and Cabedo, H., 2007, Transcriptional control of cholesterol biosynthesis in Schwann cells by axonal neuregulin 1. J Biol Chem 282:28768–78.
61. Quarles, R. H., 2002, Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration. Cell Mol Life Sci 59:1851–71.
62. Raff, M. C., Lillien, L. E., Richardson, W. D., Burne, J. F., and Noble, M. D., 1988, Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333:562–5.
63. Rechthand, E., and Rapoport, S. I., 1987, Regulation of the microenvironment of peripheral nerve: role of the blood-nerve barrier. Prog Neurobiol 28:303–43.
64. Richardson, W. D., Pringle, N., Mosley, M. J., Westermark, B., and Dubois-Dalcq, M., 1988, A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53:309–19.
65. Rowitch, D. H., 2004, Glial specification in the vertebrate neural tube. Nat Rev Neurosci 5: 409–19.
66. Rubin, L. L., and Staddon, J. M., 1999, The cell biology of the blood-brain barrier. Annu Rev Neurosci 22:11–28.
67. Saher, G., Brugger, B., Lappe-Siefke, C., Mobius, W., Tozawa, R., Wehr, M. C., Wieland, F., Ishibashi, S., and Nave, K. A., 2005, High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8:468–75.
68. Saher, G., Quintes, S., Mobius, W., Wehr, M. C., Kramer-Albers, E. M., Brugger, B., and Nave, K. A., 2009, Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci 29:6094–104.
69. Salzer, J. L., 2003, Polarized domains of myelinated axons. Neuron 40:297–318.
70. Sato, R., 2009, SREBPs: protein interaction and SREBPs. Fe b s J 276:622–7.
71. Shanmugaratnam, J., Berg, E., Kimerer, L., Johnson, R. J., Amaratunga, A., Schreiber, B. M., and Fine, R. E., 1997, Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. Brain Res Mol Brain Res 50:113–20.
72. Sherman, D. L., and Brophy, P. J., 2005, Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6:683–90.
73. Simons, M., Kramer, E. M., Macchi, P., Rathke-Hartlieb, S., Trotter, J., Nave, K. A., and Schulz, J. B., 2002, Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 157:327–36.
74. Simons, M., Kramer, E. M., Thiele, C., Stoffel, W., and Trotter, J., 2000, Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 151:143–54.
75. Simons, M., and Raposo, G., 2009, Exosomes - vesicular carriers for intercellular communication. Curr Opin Cell Biol. 21:575–81
76. Simons, M., and Trajkovic, K., 2006, Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J Cell Sci 119:4381–9.
77. Simons, M., and Trotter, J., 2007, Wrapping it up: the cell biology of myelination. Curr Opin Neurobiol 17:533–40.
78. Smith, M. E., 1968, The turnover of myelin in the adult rat. Biochim Biophys Acta 164:285–93.
79. Snipes, G. J., and Suter, U., 1997, Cholesterol and myelin. Subcell Biochem 28:173–204.
80. Spady, D. K., Huettinger, M., Bilheimer, D. W., and Dietschy, J. M., 1987, Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit. J Lipid Res 28:32–41.
81. Taveggia, C., Zanazzi, G., Petrylak, A., Yano, H., Rosenbluth, J., Einheber, S., Xu, X., Esper, R. M., Loeb, J. A., Shrager, P., Chao, M. V., Falls, D. L., Role, L., and Salzer, J. L., 2005, Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681–94.
82. Temple, S., and Raff, M. C., 1986, Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell 44:773–9.
83. Thery, C., Ostrowski, M., and Segura, E., 2009, Membrane vesicles as conveyors of immuneresponses, Nat Rev Immunol. 9(8): 581–93.
84. Trajkovic, K., Dhaunchak, A. S., Goncalves, J. T., Wenzel, D., Schneider, A., Bunt, G., Nave, K. A., and Simons, M., 2006, Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites. J Cell Biol 172:937–48.
85. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brugger, B., and Simons, M., 2008, Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244–7.
86. Verheijen, M. H., Chrast, R., Burrola, P., and Lemke, G., 2003, Local regulation of fat metabolism in peripheral nerves. Genes Dev 17:2450–64.
87. Verheijen, M. H., Camargo, N., Verdier, V., Nadra, K., de Preux Charles, A. S., Medard, J. J., Luoma, A., Crowther, M., Inouye, H., Shimano, H., Chen, S., Brouwers, J. F., Helms, J. B., Feltri, M. L., Wrabetz, L., Kirschner, D., Chrast, R., and Smit, A. B., 2009, SCAP is required for timely and proper myelin membrane synthesis. Proc Natl Acad Sci U S A 106:21383–8.
88. Webster, H. D., 1971, The geometry of peripheral myelin sheaths during their formation and growth in rat sciatic nerves. J Cell Biol 48:348–67.
89. Weimbs, T., and Stoffel, W., 1992, Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31:12289–96.
90. Woodhoo, A., and Sommer, L., 2008, Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia 56:1481–90.